Advanced search
Publication Cover
Current Eye Research Volume 32, 2007 - Issue 11
Submit an article Journal homepage
102
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Pitavastatin: Protection against Neuronal Retinal Damage Induced by Ischemia-Reperfusion Injury in Rats

Takahiro Kawaji Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan
,
Yasuya Inomata Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan
,
Akiomi Takano Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan
,
Nina Sagara Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan
,
Masaru Inatani Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan
,
Mikiko Fukushima Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan
,
Hidenobu Tanihara Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan
&
Megumi Honjo Department of Ophthalmology, Kitano Hospital, Ogimachi, Kita-ku, Osaka, Japan
 show all
Pages 991-997 | Received 13 Jun 2007, Accepted 24 Aug 2007, Published online: 02 Jul 2009

REFERENCES

  • The Scandinavian Simvastatin Survival Study (4S). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994; 344: 1383–1389
  • Shepherd J. Statin therapy in clinical practice: new developments. Curr Opin Lipidol. 1995; 6: 254–255
  • Treasure C B, Klein J L, Weintraub W S, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995; 332: 481–487
  • Delanty N, Vaughan C J. Vascular effects of statins in stroke. Stroke. 1997; 28: 2315–2320
  • Sacks F M, Pfeffer M A, Moye L A, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med. 1996; 335: 1001–1009
  • Baghdasarian S B, Jneid H, Hoogwerf B J. Association of dyslipidemia and effects of statins on nonmacrovascular diseases. Clin Ther. 2004; 26: 337–351
  • Wilson H L, Schwartz D M, Bhatt H R, et al. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol. 2004; 137: 615–624
  • Klein R, Klein B E, Tomany S C, et al. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol. 2003; 121: 1151–1155
  • McGwin G, Jr., Owsley C, Curcio C A, Crain R J. The association between statin use and age related maculopathy. Br J Ophthalmol. 2003; 87: 1121–1125
  • McGwin G, Jr., McNeal S, Owsley C, et al. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol. 2004; 122: 822–826
  • Honjo M, Tanihara H, Nishijima K, et al. Statin inhibits leukocyte-endothelial interaction and prevents neuronal death induced by ischemia-reperfusion injury in the rat retina. Arch Ophthalmol. 2002; 120: 1707–1713
  • Zambarakji H J, Nakazawa T, Connolly E, et al. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2006; 47: 2623–2631
  • Sagara N, Kawaji T, Takano A, et al. Effect of pitavastatin on experimental choroidal neovascularization in rats. Exp Eye Res. 2007; 84: 1074–1080
  • Miyahara S, Kiryu J, Yamashiro K, et al. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes. Am J Pathol. 2004; 164: 1697–1706
  • Rosenbaum D M, Rosenbaum P S, Gupta A, et al. Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid. Vision Res. 1997; 37: 3445–3451
  • Morizane C, Adachi K, Furutani I, et al. N(omega)-nitro-L-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo. Eur J Pharmacol 1997; 328: 45–49
  • Sawada A, Neufeld A H. Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res. 1999; 69: 525–531
  • Rosenson R S, Tangney C C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998; 279: 1643–1650
  • Laufs U, Liao J K. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med. 2000; 10: 143–148
  • Takemoto M, Liao J K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001; 21: 1712–1719
  • Aoki T, Nishimura H, Nakagawa S, et al. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittelforschung 1997; 47: 904–909
  • Kojima J, Fujino H, Abe H, et al. Identification of metabolites of NK-104, an HMG-CoA reductase inhibitor, in rat, rabbit and dog bile. Biol Pharm Bull. 1999; 22: 142–150
  • Kajinami K, Koizumi J, Ueda K, et al. Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia. Hokuriku NK-104 Study Group. Am J Cardiol. 2000; 85: 178–183
  • Saito Y, Yamada N, Teramoto T, et al. Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison. Arzneimittelforschung. 2002; 52: 251–255
  • Kubes P, Suzuki M, Granger D N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991; 88: 4651–4655

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.